Blonanserin is a D2/5-HT2 receptor antagonist; atypical antipsychotic.
Características y beneficios
This compound was developed by Dainippon Sumitomo. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Journal of psychiatric research, 47(2), 149-154 (2012-11-08)
There is uncertainty about the efficacy and tolerability of blonanserin in schizophrenia. PubMed, the Cochrane Library databases, PsycINFO, and Google Scholar were searched up to September 2012. A systematic review and meta-analysis of individual patient data from randomized, controlled trials
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 26(10), 1099-1102 (2010-10-19)
A rapid and sensitive method for analysis of blonanserin in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry is presented. After pretreatment of a plasma sample by solid-phase extraction, blonanserin was analyzed by the system with a C(18) column. This
Case of delirium complicated with pneumonia that improved with blonanserin administration.
Hidehiro Andoh et al.
Psychiatry and clinical neurosciences, 64(5), 588-589 (2010-10-07)
We offer many products related to serotonin receptors for your research needs.
Questions
Reviews
★★★★★ No rating value
Active Filters
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
